Midlife Hypertension Appears Detrimental to Cognitive Function

This article originally appeared here.
Share this content:
Midlife Hypertension Appears Detrimental to Cognitive Function
Midlife Hypertension Appears Detrimental to Cognitive Function

TUESDAY, Oct. 11, 2016 (HealthDay News) -- Midlife hypertension may increase risk for dementia later in life, according to a new scientific statement published online Oct. 10 in Hypertension.

Experts were selected to contribute to the statement, and were assigned topics relevant to their areas of expertise. The team reviewed the literature and summarized the available data.

The authors write that there is strong evidence of a deleterious influence of midlife hypertension on late-life cognitive function. However, the cognitive impact of late-life hypertension is less clear. The group concluded that there were insufficient data to make evidence-based recommendations.

"The upcoming release of the results of the SPRINT-MIND trial may help fill some of these knowledge gaps," according to the statement. "Despite numerous outstanding questions and caveats, personalized treatment of hypertension, taking into account age, sex, APOE genotype, metabolic traits, comorbidities, etc., remains a most promising and eminently feasible approach to safeguard vascular health and, as a consequence, brain heath."

One author disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »